High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: A preliminary report
- PMID: 33823281
- PMCID: PMC8019243
- DOI: 10.1016/j.ijid.2021.03.087
High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: A preliminary report
Abstract
Objectives: In a conventional hospital ward, we used high-flow nasal oxygen (HFNO) to treat elderly COVID-19 patients noneligible for intensive care unit transfer.
Methods: This study was conducted in the Institut Hospitalo-Universitaire Méditerranée Infection, Assistance Publique-Hôpitaux de Marseille (AP-HM), France. We used high-flow nasal oxygen (HFNO) in our conventional infectious disease ward from 15 September 2020 for elderly patients noneligible for intensive care unit transfer.
Results: Of the 44 patients (median age 83 years (57-94), mean: 80.25), 61.4% (27/44) were men. The median Charlson score was 7 (1-15). The median of the NEWS-2 score upon admission was 8 (3-11) and was 10 at the time of initiation of HFNO. The median PaO2/FiO2 ratio was 103 (71-151) prior to HNFO initiation. Among the 44 patients, 16 patients (36.4%) had been weaned from HFNO, and 28 patients had died (63.6%).
Conclusions: In this preliminary report, we observed that HFNO saved the lives of one-third of elderly COVID-19 patients who would have systematically died.
Keywords: COVID-19; Conventional hospital ward; Elderly patients; High-flow oxygen therapy; SARS-CoV2.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
References
-
- Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383. - PubMed
-
- Frieden T.R. Evidence of health decision making-beyond randomized controlled trials. N Engl J Med. 2017;377:465–475. - PubMed
-
- Guy T., Créac’hcadec A., Ricordel C., Salé A., Arnouat B., Bizec J.L. High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU. Eur Respir J. 2020;(September) doi: 10.1183/13993003.01154-2020. Online ahead of print. PMID: 32859678. Free PMC article. - DOI - PMC - PubMed
-
- Johns Hopkins University . 2021. Coronavirus resource center. COVID-19 dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins University (JHU) [Accessed at https://coronavirus.jhu.edu/map.html on 13 November 2020]
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous